Olympus Unveils Groundbreaking AI Endoscopy Platform at DDW 2025

Olympus, a leader in medical technology, is set to make waves at the Digestive Disease Week (DDW) 2025 with the unveiling of its innovative OLYSENSE™ Platform, featuring the CADDIE™ computer-aided detection device. This exciting development, taking place May 4-6 in San Diego, marks the first introduction of this cutting-edge technology to the United States.

The OLYSENSE Platform leverages cloud-based artificial intelligence (AI) to enhance the capabilities of gastroenterologists in detecting polyps during colonoscopy procedures. This technology aims to revolutionize clinical decision-making, thereby improving patient outcomes and ensuring safer health interventions. Miquel Àngel García, Senior Vice President and General Manager for Endoscopy Ecosystem Solutions at Olympus, remarked, "We are thrilled to bring our CADe AI solution to the U.S. market as part of the visionary OLYSENSE™ Platform."

Comprehensive Portfolio of Diagnostic Solutions

During DDW 2025, Olympus will showcase its entire suite of advanced solutions and technologies designed for managing gastrointestinal (GI) diseases. Joining the OLYSENSE Platform will be well-established tools such as the ENDOCUFF Vision™ device and Texture and Color Enhancement Imaging (TXI™) technology. These tools have shown promise in aiding healthcare professionals in performing high-quality endoscopic assessments.

The range of products presented at the conference will not only include the new OLYSENSE Platform but also advanced hemostasis instruments and the recently launched EU-ME3 ultrasound processor, optimized for seamless integration with conventional endoscopy processes. Using high-resolution imaging, the EU-ME3 will support the detection and characterization of lesions, employing features like Contrast Harmonic Echo (CHE) and Shear Wave Quantification (SWQ).

Educational Opportunities for Physicians

At the Olympus exhibit, booth #5129, physicians will have access to a variety of educational sessions focused on improving adenoma detection rates (ADR). Notable speakers include Dr. Nikhil Kumta from NYU Langone Health, who will discuss the advanced tools for third-space endoscopy procedures, and Dr. Doug Rex, a leading ADR expert, who will explore leveraging technology to enhance adenoma detection.

Many of these physician-led discussions are part of a collaborative effort with the American Society for Gastrointestinal Endoscopy (ASGE) to provide critical insights into the latest advancements in endoscopic practices. These sessions aim to equip healthcare providers with knowledge and tools that can potentially improve detection rates in routine clinical settings.

On Monday, May 5th, Dr. Jason Samarasena from UCI Health will shine a light on the innovations involved in advanced third-space endoscopy, specifically looking at procedures like peroral endoscopic myotomy (POEM). Also scheduled is a presentation by Dr. Dennis Yang from Advent Health Medical Group, focusing on the effectiveness of image-enhanced endoscopy during resection procedures.

Commitment to Patient Care

The commitment of Olympus to making healthcare safer and more effective is underscored through its continuous innovation in medical technology. The company has been a pioneer in developing solutions that enhance patient diagnostics and treatment over the last century. Their optimized tools and systems aim at elevating clinical standards in targeted disease states, reaffirming Olympus’s role as a global leader in the MedTech industry.

While the CADDIE device offers groundbreaking advances in image recognition for polyps, Olympus reminds that these technologies, including the TXI and RDI, are not intended to replace histopathological sampling for diagnosis. As with any innovative device, safety precautions are paramount, and Olympus is committed to educating users about the correct application of their technologies to ensure patient safety and effective results.

For more detailed insights about the OLYSENSE Platform and its various applications in clinical settings, visit the Olympus website or the dedicated DDW 2025 page. Olympus continues to forge paths in the health tech sector, aiming to transform the future of endoscopy and enhance the way patients receive care.

Stay tuned for more updates from DDW 2025, where technology meets healthcare excellence.